Capitalizing glycomic changes for improved biomarker-based cancer diagnostics [0.03%]
基于生物标志物的癌症诊断中利用糖组学变化以获得更好的诊断效果
Maria Luísa S Silva
Maria Luísa S Silva
Cancer serum biomarkers are valuable or even indispensable for cancer diagnostics and/or monitoring and, currently, many cancer serum markers are routinely used in the clinic. Most of those markers are glycoproteins, carrying cancer-specifi...
Real world outcomes in patients with neuroendocrine tumor receiving peptide receptor radionucleotide therapy [0.03%]
肽受体核素治疗神经内分泌肿瘤患者的预后因素分析
Stijn Hentzen,Kathan Mehta,Raed Moh&#x;d Taiseer Al-Rajabi et al.
Stijn Hentzen et al.
Aim: 177Lu-Dotatate (Lu-177), a form of peptide receptor radionuclide therapy (PRRT), was approved by Food and Drug Administration (FDA) for the treatment of somatostatin-receptor-positive neuroendocrine tumors (NETs) in ...
Liquid biopsy: an examination of platelet RNA obtained from head and neck squamous cell carcinoma patients for predictive molecular tumor markers [0.03%]
液体活检：从头颈部鳞状细胞癌患者中获取血小板RNA检测预测性分子肿瘤标志物的一项研究
Lisa T Huber,Johann M Kraus,Jasmin Ezić et al.
Lisa T Huber et al.
Aim: Recently, a tumor cell-platelet interaction was identified in different tumor entities, resulting in a transfer of tumor-derived RNA into platelets, named further "tumor-educated platelets (TEP)". The present pilot s...
Spontaneous regression of a metastatic carcinoma transmitted by a kidney graft [0.03%]
自发性转移癌的消退案例——移植肾脏携带的癌症转移到了接受者身上但又自行消失了
Mikhail V Kiselevskiy,Elena G Gromova,Nikolay A Kozlov et al.
Mikhail V Kiselevskiy et al.
Transmission of a malignancy from a donor's organ to the recipient of the graft is a rare event, though it is a severe complication that can result in a poor outcome. Usually, immunosuppressive therapy is discontinued and the allograft is r...
Increasing differential diagnosis between lipoma and liposarcoma through radiomics: a narrative review [0.03%]
通过影像组学提高脂肪瘤和脂肪肉瘤鉴别诊断的叙事综述研究
Raffaele Natella,Giulia Varriano,Maria Chiara Brunese et al.
Raffaele Natella et al.
Soft tissue sarcomas (STSs) are rare, heterogeneous, and very often asymptomatic diseases. Their diagnosis is fundamental, as is the identification of the degree of malignancy, which may be high, medium, or low. The Italian Medical Oncology...
Development and validation of an infrared-artificial intelligence software for breast cancer detection [0.03%]
一种用于乳腺癌检测的红外-人工智能软件的开发与验证
Enrique Martín-Del-Campo-Mena,Pedro A Sánchez-Méndez,Eva Ruvalcaba-Limon et al.
Enrique Martín-Del-Campo-Mena et al.
Aim: In countries where access to mammography equipment and skilled personnel is limited, most breast cancer (BC) cases are detected in locally advanced stages. Infrared breast thermography is recognized as an adjunctive ...
Transforming growth factor-β signaling: from tumor microenvironment to anticancer therapy [0.03%]
转化生长因子-β信号通路：从肿瘤微环境到抗癌治疗
Max Kam-Kwan Chan,Emily Lok-Yiu Chan,Zoey Zeyuan Ji et al.
Max Kam-Kwan Chan et al.
Transforming growth factor-β (TGF-β) signaling is an important pathway for promoting the pathogenesis of inflammatory diseases, including cancer. The roles of TGF-β signaling are heterogeneous and versatile in cancer development and prog...
Ginnalin A and hamamelitannin: the unique gallotannins with promising anti-carcinogenic potential [0.03%]
独特的没食子鞣花酸甘及其有希望的抗癌潜力相关的吉拉林A和.hamamelitannin
Rippin,Vikas Beniwal,Ajay Sharma et al.
Rippin et al.
Tannins are secondary metabolites that belong to the family of polyphenolic compounds and have gained a huge interest among researchers due to their versatile therapeutic potential. After lignin, these are the second most abundant polypheno...
Clinicopathological relevance of stem cell marker growth and differentiation factor 3 in esophageal squamous cell carcinoma [0.03%]
生长和分化因子3在食管鳞癌中的临床病理意义分析
Sara Tahbazzadeh Moghaddam,Mohammad Mahdi Forghanifard
Sara Tahbazzadeh Moghaddam
Esophageal squamous cell carcinoma (ESCC) is the second leading cause of cancer-related deaths in Iran, often diagnosed in advanced stages with a poor prognosis. Growth and differentiation factor 3 (GDF3) is a member of the transforming gro...
Complete response to third-line treatment with trifluridine/tipiracil (TAS-102) in stage IV colon adenocarcinoma [0.03%]
三线使用曲氟尿苷/替匹拉西(TAS-102)治疗IV期结肠腺癌的完全应答案例报告
Celia Lara-Morga,Magda Palka-Kotlowska,Sara Custodio-Cabello et al.
Celia Lara-Morga et al.
A clinical case of a 61-year-old female diagnosed with stage IV right colon adenocarcinoma (unresectable liver and multiple lymph node metastases at the time of diagnosis), Kirsten rat sarcoma viral oncogene homolog (KRAS), neuroblastoma ra...